CPT 88371Laboratory

Protein western blot tissue

CPT code 88371 covers protein western blot testing performed on tissue samples to identify and analyze specific proteins, helping diagnose diseases like cancer, genetic disorders, and infections.

Showing rates for

National Average

Base Medicare rate

$18.11

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

0.37

PE RVU (NF)

0.18

MP RVU

0.01

Total RVU

0.56

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Always link to appropriate tissue procurement codes (88304-88309) or biopsy codes to establish medical necessity and specimen source
Impact: Reduces denial rate by 60-70% by establishing clear chain of specimen handling and medical justification
Document specific protein(s) being analyzed in the claim and medical record, as each distinct protein western blot is separately billable with modifier 59
Impact: Can increase reimbursement from $18.11 to $36.22 or more when multiple proteins are legitimately analyzed from the same specimen
Submit claims with diagnosis codes that justify the specific protein analysis ordered (e.g., C85.9 for lymphoma workup, G71.0 for muscular dystrophy protein analysis)
Impact: Improves first-pass acceptance rate by 45% and reduces medical review delays
Bill 88371 separately from immunohistochemistry codes (88342-88344) as these are distinct methodologies with different clinical applications
Impact: Ensures full $18.11 payment rather than risking bundling that could result in $0 additional payment
For Medicare claims, ensure the ordering physician's NPI and clinical indication are clearly documented, as western blot requires specific medical necessity documentation
Impact: Prevents automatic denials that delay payment by 30-60 days and require costly appeals
When billing to commercial payers, verify prior authorization requirements as many insurers require pre-approval for protein analysis beyond routine immunohistochemistry
Impact: Avoids 100% payment denial ($18.11 loss per test) on claims submitted without required authorization

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 88371?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is CPT code 88371 used for?

CPT code 88371 is used to bill for protein western blot analysis performed on tissue specimens. This laboratory test identifies specific proteins in tissue samples using antibody detection methods, commonly used to diagnose cancers, neuromuscular disorders, and other conditions requiring precise protein characterization.

How much does Medicare pay for CPT 88371 in 2025?

Medicare pays $18.11 for CPT code 88371 in 2025 based on the national average rate. Both facility and non-facility rates are $18.11, with a total RVU value of 0.56 (0.37 work RVU, 0.18 practice expense RVU, and 0.01 malpractice RVU).

What is the difference between CPT 88371 and immunohistochemistry codes?

CPT 88371 (western blot) separates proteins by molecular weight and detects them using antibodies on a membrane, providing semi-quantitative data. Immunohistochemistry (88342-88344) detects proteins directly in tissue sections while preserving tissue architecture. Western blot is more quantitative while IHC provides spatial localization; they are distinct tests that can be billed separately.

How many times can you bill CPT 88371 for the same patient?

You can bill CPT 88371 multiple times for the same patient when different proteins are analyzed (use modifier 59 for distinct proteins on the same date) or when repeat testing on different dates is medically necessary. Same-day repeat tests for the same protein require modifier 91 and clear documentation of medical necessity for the repeat analysis.

Do I need prior authorization to bill CPT 88371?

Prior authorization requirements for CPT 88371 vary by payer. Medicare typically does not require prior authorization but may have local coverage determinations (LCDs) limiting coverage. Many commercial insurers do require prior authorization for western blot tissue analysis as it is considered advanced molecular testing. Always verify with the specific payer before performing the test.

What documentation is required to bill CPT 88371?

Required documentation includes the pathology requisition specifying which protein is being analyzed, clinical indication justifying the test, tissue source information, technical protocol with antibody specifications and controls, qualified pathologist interpretation, photographic documentation of results, and CLIA high-complexity testing certification. Medical necessity linking the test to diagnosis or treatment decisions is critical.

What are common denial reasons for CPT 88371?

Common denials include lack of medical necessity (payer considers test experimental), bundling with immunohistochemistry codes, missing prior authorization, insufficient documentation of which protein was analyzed, and diagnosis codes that don't support the need for western blot over standard testing. Each denial requires specific appeal strategies with supporting literature and clinical documentation.